LQDA Q4 2019 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$837,011

Balance Sheet

Total Assets

$69M

Total Liabilities

$34M

Stockholders' Equity

$35M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$568,402	-100.0%
Gross Profit	$0	-$121M	+100.0%
Operating Income	-$14M	-$10M	-42.9%
Net Income	-$14M	-$10M	-49.6%